Literature DB >> 8382493

Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes.

K M Rice1, M A Turnbow, C W Garner.   

Abstract

One of the first steps that follows insulin receptor activation is the tyrosine phosphorylation of the 160-185 kDa insulin receptor substrate IRS-1. In 3T3-L1 adipocytes, expression of IRS-1 is down-regulated by chronic exposure to insulin. Expression of IRS-1 mRNA is essentially unchanged. However, [35S]Met pulse-chase labeling demonstrates that the rate of degradation of IRS-1 protein is about 10 times faster in insulin-treated cells than in basal cells. The down-regulation occurs in the presence of cycloheximide or actinomycin D and therefore is not dependent upon protein synthesis. Chloroquine does not inhibit the insulin-induced degradation, suggesting that the site of proteolysis is an extra-lysosomal compartment. The insulin-regulated proteolysis of IRS-1 may contribute to the insulin resistance seen in these cells following chronic exposure to insulin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382493     DOI: 10.1006/bbrc.1993.1143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2.

Authors:  A V Chibalin; M Yu; J W Ryder; X M Song; D Galuska; A Krook; H Wallberg-Henriksson; J R Zierath
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress.

Authors:  R Potashnik; A Bloch-Damti; N Bashan; A Rudich
Journal:  Diabetologia       Date:  2003-05-15       Impact factor: 10.122

3.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

4.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

5.  Selective insulin resistance in adipocytes.

Authors:  Shi-Xiong Tan; Kelsey H Fisher-Wellman; Daniel J Fazakerley; Yvonne Ng; Himani Pant; Jia Li; Christopher C Meoli; Adelle C F Coster; Jacqueline Stöckli; David E James
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

6.  Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.

Authors:  K L Anil Kumar; A R Marita
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

7.  Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.

Authors:  Stéphane Dalle; Takeshi Imamura; David W Rose; Dorothy Sears Worrall; Satoshi Ugi; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase.

Authors:  J F Tanti; T Grémeaux; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

Review 9.  Modulation of insulin action.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

10.  beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.

Authors:  Isao Usui; Takeshi Imamura; Jie Huang; Hiroaki Satoh; Sudha K Shenoy; Robert J Lefkowitz; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.